Scholarlink

<p>Device-detected atrial fibrillation (DDAF), like clinical atrial fibrillation (AF), is also associated with an increased risk of thromboembolic events, although the risk appears to be significantly lower. The efficacy and safety of oral anticoagulation in DDAF were investigated in two large randomized trials (NOAH-AFNET&#xa0;6 and ARTESIA&#xa0;[<CitationRef CitationID="CR13">13</CitationRef>, <CitationRef CitationID="CR19">19</CitationRef>]). They showed a&#xa0;low rate of ischemic strokes without anticoagulation (about 1% per year). This risk can still be reduced by therapeutic anticoagulation, but the risk of severe bleeding increases. In the recently published position paper [<CitationRef CitationID="CR36">36</CitationRef>] of the German Society of Cardiology, the current study situation was presented and expert recommendations were given on how to deal with DDAF.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Device-detektiertes Vorhofflimmern – was nun?

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月29日

查看全文
  • Tobias Tönnis,
  • Nina Becher,
  • Ralf Birkemeyer,
  • David Duncker,
  • Lars Eckardt,
  • Klaus Gröschel,
  • Dominik Linz,
  • Christian Meyer,
  • Florian Straube,
  • Arian Sultan,
  • Rolf Wachter,
  • Maura Zylla,
  • Paulus Kirchhof

摘要

Device-detected atrial fibrillation (DDAF), like clinical atrial fibrillation (AF), is also associated with an increased risk of thromboembolic events, although the risk appears to be significantly lower. The efficacy and safety of oral anticoagulation in DDAF were investigated in two large randomized trials (NOAH-AFNET 6 and ARTESIA [13, 19]). They showed a low rate of ischemic strokes without anticoagulation (about 1% per year). This risk can still be reduced by therapeutic anticoagulation, but the risk of severe bleeding increases. In the recently published position paper [36] of the German Society of Cardiology, the current study situation was presented and expert recommendations were given on how to deal with DDAF.